The cortico-diaphragmatic pathway involvement in amyotrophic lateral sclerosis: Neurophysiological, respiratory and clinical considerations

https://doi.org/10.1016/j.jns.2006.05.059Get rights and content

Abstract

Cortico-diaphragmatic pathway was investigated by means of transcranial magnetic stimulation (TMS), in 14 patients affected by definite amyotrophic lateral sclerosis (ALS) without clinical signs of respiratory impairment. Spirometry, gas analysis, and measurement of static inspiratory and expiratory pressures were performed in all patients.

Forced vital capacity, forced expiratory volume at the first and second peak expiratory flow, sniff effort from FRC level (SNIP), maximal inspiratory and expiratory pressure at mouth (MIP/MEP), maximal transdiaphragmatic pressure (Pdimx) were considered. TMS was performed, recording by surface electrodes from hemidiaphragm, bilaterally. Latency of cortical and spinal motor-evoked potentials (Cx-MEP/Sp-MEP) and central motor conduction time (CMCT) were measured.

None of the patients showed altered spirometry and gas levels. Seven patients showed decreased Pdimx and eight of MEP values. Four patients showed a delayed Sp-MEP. In one patient the Cx-MEP was abolished while the mean values of both Cx-MEP and CMCT were significantly increased (19.2 ± 4.1 ms, P < 0.0001; 10.8 ± 4.8 ms, P < 0.0001). Cx-MEP and CMCT did not show significant correlations with any of the respiratory measures. The patients with prolonged Sp-MEP, showed longer disease duration, lower Norris score, lower Pdimx and MEP values. In conclusion, cortico-diaphragmatic study is a sensitive measure to reveal subclinical diaphragmatic impairment although not correlated to respiratory measures.

Introduction

Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive disease characterised by signs of lower motor neurone involvement variably combined with those of upper motor neurone lesion, leading inexorably to death. The fatal event, in most cases, is due to ventilatory failure caused by respiratory muscle weakness [1].

An impaired diaphragmatic strength is a major factor for the respiratory failure in the ALS patients, and its accurate and reliable measurement, a major concern in the management of the ALS patient.

The measure of the transdiaphragmatic pressure has been considered a more reliable and accurate assessment of the diaphragmatic strength [2], [3]. Nevertheless the use of such measure can be questionable in a large population of ALS patients, who may frequently present severe bulbar signs and deglutition impairment.

More recently, transcranial magnetic stimulation has been demonstrated to be highly informative of the upper motor neurone impairment in the respiratory drive in several neurological disorders [4], [5], [6], [7], [8], with great advantage as to being non-invasive, well tolerated by the patients, and non-volitional, and hence independent by their compliance. Nevertheless, this technique has been scantly employed in the study of the respiratory function of ALS patients [9], [10].

In a recent paper [9], transcranial magnetic stimulation recording from diaphragm was applied to a group of ALS patients, according to the presence or absence of dyspnea. Cortico-diaphragmatic abnormalities were common in ALS patients and more pronounced in those reporting dyspnea. Such dysfunction could stem from upper motor neurone abnormalities and was linked to dyspnea. However, the clinical relevance of the use of central motor conduction time (CMCT) from diaphragm remains to be investigated. For this reason we performed the present study aimed at investigating the respiratory function in a sample of ALS patients without severe bulbar signs and clinical respiratory symptoms, to evaluate the role of the cortico-diaphragmatic involvement in the respiratory dynamic of these patients and its relationship with either invasive or non-invasive conventional respiratory tests.

Section snippets

Materials and methods

Fourteen ALS patients (1 female and 13 males; mean age 51.9 ± 11.2 years, range 31–60 years) without dyspnoea were selected for the study. The diagnosis of motor neurone disease was based on the patient's history, clinical examination and neurophysiological tests. All the patients had “definite” forms of ALS according to the El Escorial diagnostic criteria [11]. The mean disease duration was 28.7 ± 10.1 months (range 13–46 months). The severity of the disease was measured by the Norris score [12].

Respiratory tests

The mean values of spirometric and gas analysis for the whole population of patients were in the normal range. None of the patients showed PCO2 and PO2 alterations. Only two patients (14.3%) showed decreased PEF values. Four and three out of fourteen patients (28.5% and 21.4%) showed pathological values of MIP and SNIP, respectively; these percentages markedly increased at Pdimx and MEP tests: in fact seven and eight patients (50% and 57.1%), respectively, presented altered values. The detailed

Discussion

The present study investigated the cortico-diaphragmatic pathway by means of magnetic stimulation in a sample of ALS patients without signs and symptoms of respiratory failure, and without severe bulbar involvement, and it combined the non-invasive and non-volitional neurophysiological technique of magnetic stimulation, with validated non-invasive/invasive, volitional respiratory tests.

Magnetic stimulation of the motor cortex seems particularly indicated to investigate the neurophysiological

Acknowledgements

We are grateful to Dr. Lorenzo Appendini for the measurement of the respiratory pressures.

References (53)

  • H. Stewart et al.

    Electromyography of respiratory muscles in amyotrophic lateral sclerosis

    J Neurol Sci

    (2001)
  • G.C. Rikard-Bell et al.

    Brainstem projections to the phrenic nucleus: a HRP study in the cat

    Brain Res Bull

    (1984)
  • H. Tsukagoshi et al.

    Morphometric quantification of the cervical limb motor cells in controls and in amyotrophic lateral sclerosis

    J Neurol Sci

    (1979)
  • N.C. Vitacca et al.

    Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis

    Eur Respir J

    (1997)
  • R.A. Lyall et al.

    Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis

    Brain

    (2001)
  • A. Lagueny et al.

    Study of central and peripheral conductions to the diaphragm in 22 patients with definite multiple sclerosis

    Electromyogr Clin Neurophysiol

    (1998)
  • T. Similowski et al.

    Impairment of central motor conduction to the diaphragm in stroke

    Am J Respir Crit Care Med

    (1996)
  • U. Zifko et al.

    Respiratory electrophysiological studies in Guillain–Barre syndrome

    J Neurol Neurosurg Psychiatry

    (1996)
  • U.A. Zifko et al.

    Central and peripheral respiratory electrophysiological studies in myotonic dystrophy

    Brain

    (1996)
  • T. Similowski et al.

    Diaphragmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis

    Eur Respir J

    (2000)
  • L. Zhuang et al.

    Diaphragmatic motor evoked potential in amyotrophic lateral sclerosis patients

    Zhonghua Nei Ke Za Zhi

    (2002)
  • F.H. Norris et al.

    The administration of guanidine in amyotrophic lateral sclerosis

    Neurology

    (1974)
  • I. Cerveri et al.

    Reference values of arterial oxygen tension in the middle-aged and elderly

    Am J Respir Crit Care Med

    (1995)
  • J. Leech et al.

    Respiratory pressures and function in young adults

    Am Rev Respir Dis

    (1983)
  • C. Bruschi et al.

    Reference values of maximal inspiratory mouth pressures: a population based study

    Am Rev Respir Dis

    (1992)
  • J. Newsom-Davis et al.

    Diaphragm function and alveolar hypoventilation

    Q J Med

    (1976)
  • Cited by (18)

    • The role of the TMS parameters for activation of the corticospinal pathway to the diaphragm

      2022, Clinical Neurophysiology
      Citation Excerpt :

      The circumstance that monophasic pulses require higher stimulation-intensity than biphasic pulses represents a considerable limiting factor in the inspection of the diaphragm by TMS. In fact, most of such studies, with some exceptions (e.g., (Laviolette et al., 2013; Miscio et al., 2006)), have been performed by means of devices providing only monophasic pulses (i.e. Magstim 200), hence the stimulations have been accomplished with maximal or supramaximal TMS-device output (e.g., see (Davey et al., 1996; Kawaguchi et al., 2000; Lefaucheur and Lofaso, 2002; Lissens and Vanderstraeten, 1996; Maskill et al., 1991; Murphy et al., 1990; Rosler et al., 1994; Welch et al., 2020; Zifko et al., 1996)). In the present study we were not able to derive any MEPs of the diaphragm in 6 out of 19 subjects when using monophasic-TMS even at 100% MSO, whereas diMEPs were derived in all 20-test subjects after stimulation with biphasic-posterior-anterior-TMS.

    • Electrophysiological assessment of respiratory function

      2022, Handbook of Clinical Neurology
      Citation Excerpt :

      In 1 study, 14 ALS patients who did not have symptoms of respiratory impairment were investigated with transcranial magnetic stimulation and half of them had reduced MEP amplitudes (Miscio et al., 2006). Besides, both the mean values of CMCT and cortical stimulation MEP latency were significantly prolonged in ALS patients (Miscio et al., 2006). The results showed that transcranial magnetic stimulation is a sensitive tool to survey the subclinical diaphragmatic involvement.

    • Breathing pattern in a phase I clinical trial of intraspinal injection of autologous bone marrow mononuclear cells in patients with amyotrophic lateral sclerosis

      2016, Respiratory Physiology and Neurobiology
      Citation Excerpt :

      It has been shown in large retrospective studies that a high Forced Vital Capacity (FVC) predicts a better survival rate (Czaplinski et al., 2006). However, there is data suggesting that the diaphragm motor cortex may be affected even before the symptoms start (Nichols et al., 2013; Miscio et al., 2006). Moreover, patients with normal lung function and preserved diaphragmatic function have desaturation episodes during sleep which could be related to central drive dysfunction (Atalaia et al., 2007).

    • Usefulness of phrenic latency and forced vital capacity in patients with ALS with latent respiratory dysfunction

      2015, Clinical Neurophysiology
      Citation Excerpt :

      A previous study showed that ALS patients without symptoms of pulmonary dysfunction had decreased amplitude and increased latency of phrenic CMAP; however, their PFT results were abnormal (FVC (%), 52.8 ± 17.6 (mean ± SD)) (Sathyaprabha et al., 2010). Another study using TMS showed that the latency of cervical motor evoked potential (MEP) was increased in the phrenic nerve of patients with ALS without respiratory symptoms and PFT deficit (FVC (%) <80) (Miscio et al., 2006), which was consistent with our results. Notably, our study implies that ALS patients with normal value ranges in PFT, already have early respiratory dysfunction, which could be reflected by phrenic latency as well as FVC (%) values.

    • Ventilatory control in ALS

      2013, Respiratory Physiology and Neurobiology
      Citation Excerpt :

      However, the diaphragm motor cortex (and voluntary influences on breathing) may be affected prior to the onset of symptom onset due to spinal, respiratory motor neurons (Miscio et al., 2006). Indeed, it has been suggested that deterioration of motor cortex pathways may predict imminent respiratory compromise (Miscio et al., 2006). Although respiratory motor neuron degeneration occurs in ALS patients, the onset and progression of motor neuron death is not known (Su et al., 1996; Motoi et al., 1998; Tsuchiya et al., 2002; Hashimoto et al., 2008; Cifra et al., 2011; Kobayashi et al., 2011).

    View all citing articles on Scopus
    View full text